Metraipolis › archive › dc_b8cf0bccc576

The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke — Europe PMC PMID:41901278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41901278
DOI
10.3390/ph19030431
License (as archived)
solo-consultazione
Archived
2026-11-05T02:16:53.717Z
SHA-256 of the archived text
88436fda8c7a6532bd77d8e1b5c3a611f2907c9d2f42564c5eb1bba890e127ab
Stable URL of this page
https://metraipolis.com/documento/dc_b8cf0bccc576

How to cite

The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke — Europe PMC PMID:41901278 — Europe PMC (en), https://europepmc.org/article/MED/41901278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b8cf0bccc576 (Metraipolis archive dc_b8cf0bccc576, sha256 88436fda8c7a6532bd77d8e1b5c3a611f2907c9d2f42564c5eb1bba890e127ab)
BibTeX
@misc{dcb8cf0bccc576,
  title = {The Senolytic Drug Navitoclax Protects the Brain After Experimental Ischemic Stroke — Europe PMC PMID:41901278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41901278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b8cf0bccc576; sha256 88436fda8c7a6532bd77d8e1b5c3a611f2907c9d2f42564c5eb1bba890e127ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41901278. Agents can read the archived copy with the MCP tool read_document.